SLC7A11 promotes HCC metastasis by increasing programmed death ligand 1 and colony-stimulating factor 1, and its high expression is linked to poor tumor differentiation and an advanced tumor-node-metastasis stage 25. Here, CSF1 is linked to hepatocellular carcinoma.